Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wolinsky

Showing results (51-60 of 331) with videos related to

Pageof 34
Sort By:
Experimental Cell Research|January 1, 1982
The production of a membrane by purified oligodendroglia maintained in cultureS E Poduslo, K Miller, J S Wolinsky
Virology|October 30, 1981
A persistent infection of Vero cells by egg-adapted mumps virusM McCarthy, J S Wolinsky, R A Lazzarini
Journal of the Neurological Sciences|December 22, 1999
The contribution of magnetic resonance imaging in the differential diagnosis of the damage of the cerebral hemispheresR I Grossman, L Kappos, J S Wolinsky
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 11, 2001
Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imagingR Sharma, P A Narayana, J S Wolinsky
Annals of Neurology|March 1, 1977
Isolated brain capillaries: a model for the study of lead encephalopathyG W Goldstein, J S Wolinsky, J Csejtey
The Journal of General Virology|March 1, 1993
Mapping cell-mediated immunodominant domains of the rubella virus structural proteins using recombinant proteins and synthetic peptidesA E Lovett, M McCarthy, J S Wolinsky
Journal of Neuroimmunology|April 1, 1989
Effect of cyclosporine on rubella virus-specific immune responses in chronic progressive multiple sclerosisA Nath, J S Wolinsky, R H Kerman
Annals of Neurology|January 1, 1982
Hematogenous origin of the inflammatory response in acute poliomyelitisJ S Wolinsky, B Jubelt, S Burke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 1997
T cell-T cell activation in multiple sclerosisJ W Lindsey, R H Kerman, J S Wolinsky
Annals of Neurology|January 13, 2000
Combination therapy with glatiramer acetate (copolymer-1) and a type I interferon (IFN-alpha) does not improve experimental autoimmune encephalomyelitisS A Brod, J W Lindsey, J S Wolinsky
Pageof 34

Showing results (51-60 of 331) with videos related to

Sort By:
Pageof 34
Experimental Cell Research|January 1, 1982
The production of a membrane by purified oligodendroglia maintained in cultureS E Poduslo, K Miller, J S Wolinsky
Virology|October 30, 1981
A persistent infection of Vero cells by egg-adapted mumps virusM McCarthy, J S Wolinsky, R A Lazzarini
Journal of the Neurological Sciences|December 22, 1999
The contribution of magnetic resonance imaging in the differential diagnosis of the damage of the cerebral hemispheresR I Grossman, L Kappos, J S Wolinsky
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 11, 2001
Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imagingR Sharma, P A Narayana, J S Wolinsky
Annals of Neurology|March 1, 1977
Isolated brain capillaries: a model for the study of lead encephalopathyG W Goldstein, J S Wolinsky, J Csejtey
The Journal of General Virology|March 1, 1993
Mapping cell-mediated immunodominant domains of the rubella virus structural proteins using recombinant proteins and synthetic peptidesA E Lovett, M McCarthy, J S Wolinsky
Journal of Neuroimmunology|April 1, 1989
Effect of cyclosporine on rubella virus-specific immune responses in chronic progressive multiple sclerosisA Nath, J S Wolinsky, R H Kerman
Annals of Neurology|January 1, 1982
Hematogenous origin of the inflammatory response in acute poliomyelitisJ S Wolinsky, B Jubelt, S Burke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 1997
T cell-T cell activation in multiple sclerosisJ W Lindsey, R H Kerman, J S Wolinsky
Annals of Neurology|January 13, 2000
Combination therapy with glatiramer acetate (copolymer-1) and a type I interferon (IFN-alpha) does not improve experimental autoimmune encephalomyelitisS A Brod, J W Lindsey, J S Wolinsky
Pageof 34